Developer docs
API playgroundTry for free, no card

Search company profiles

Solutex

Full company profile

uuid0004etc

Namestring
Solutex
Legal namestring
SOLUTEX GC S.L.
Websiteurl
solutexcorp.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Solutex GC S.L. is a Spain-based, privately held B2B ingredient manufacturer founded in 2004 and headquartered in Alcobendas, Madrid, with a dedicated manufacturing and laboratory campus in Mallén, Zaragoza. The company produces highly concentrated omega-3 EPA and DHA ingredients and Specialized Pro-Resolving Mediators (SPMs), selling to dietary supplement, medical nutrition, pharmaceutical, and cosmetics manufacturers across more than four continents via direct B2B sales and regional distribution.

Its product portfolio is anchored on four ingredient brands — Omegatex Marine Sourced, Omegatex Plant Based (algal, vegan), MaGOmega (microalgae monoglyceride form), and Lipinova (SPM concentrate) — all enabled by a proprietary technology stack centered on Flutex supercritical CO2 fluid extraction and chromatography (enabling up to 97% EPA potency and GRAS status), Cleantex purification and deodorization (patented for heavy metal, PCB, and dioxin removal), and Emugel nano-emulsion for water-soluble delivery. Manufacturing follows a zero-waste, circular-economy model certified under multiple ISO standards, IFOS, Friend of the Sea, GOED, IFFO, Kosher, Halal, and V-Label Vegan.

Solutex monetizes primarily through one-time bulk ingredient sales to brand owners and OEMs, augmented by pharmaceutical licensing (inbound Maresins 1 license from Harvard, developed through subsidiary Maresins BioPharma), specialized Resolution Physiology Laboratory services for SPM bioactivity validation, and an exclusive EU27 distribution agreement with BTC Europe (BASF group) signed April 2, 2025. Pricing is quote-based B2B; the company holds a significant minority stake investment from Nexxus Iberia private equity (January 2022) and operates wholly-owned subsidiaries Azur Global Nutrition (SPM nutrition) and Maresins BioPharma (pharmaceuticals).

Short descriptiontext

Solutex is a Spain-based B2B manufacturer of highly concentrated omega-3 EPA and DHA ingredients and patented SPM lipid fractions, supplying dietary supplement, medical nutrition, pharmaceutical, and cosmetics formulators worldwide via proprietary supercritical CO2 extraction technology and exclusive distribution partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAlcobendas, Spain
HQ citystring
Alcobendas
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
omega-3 ingredients, marine omega-3 concentrates, algae omega-3, SPM ingredients, EPA DHA manufacturing
Industry4 codes
PRIMARYAFAJAKAC
Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJALAK
Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates)
Agriculture & Food Production/Food Ingredients & Additives/Fats & Oils Ingredients (Edible Oils, Specialty Fats, Lipid Systems)
SECONDARYAFAJAKAK
Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYCRADAOAO
Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends)
NAICS code1 code
  • Fats and Oils Refining and Blending311225
SIC code3 codes
  • Fats & Oils2070
  • Medicinal Chemicals & Botanical Products2833
  • Miscellaneous Chemical Products2890
Product category
Omega-3 Nutritional Ingredients
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Omega-3 Bulk Ingredients
TypeOne Time License
Description

Sale of bulk omega-3 ingredients including Omegatex Marine Sourced, Omegatex Plant Based, MaGOmega, and Lipinova to dietary supplements, medical nutrition, pharmaceutical and cosmetics manufacturers. Products sold in various forms (EE, TG, DG, MAG) with customized ratios and potencies. Revenue generated through direct B2B sales and distribution partnerships.

solutexcorp.com
2Pharmaceutical Licensing
TypeLicensing Royalties
Description

Licensing of SPM patents including Maresins from Harvard University for pharmaceutical ingredient development. Development of pharmaceutical applications from SPM Maresins 1 as potent immunoresolvant through subsidiary Maresins BioPharma.

solutexcorp.com
3Resolution Physiology Laboratory Services
TypeProfessional Services
Description

Specialized laboratory services to observe SPM activity levels and inflammatory parameters in biological samples. Supports customer product development and validates SPM ingredient efficacy.

solutexcorp.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Omegatex
Description

Premium omega-3 ingredient brand including Marine Sourced (fish oil) and Plant Based (algae oil) product lines offering EPA and DHA concentrates

solutexcorp.com
+6 more records
Core offering1 text field

Solutex manufactures and sells highly concentrated omega-3 EPA and DHA fatty acid ingredients sourced from fish oil and microalgae, as well as patented Specialized Pro-Resolving Mediators (SPM) ingredients, serving dietary supplements, medical nutrition, pharmaceutical, and cosmetics manufacturers. Products are offered under the Omegatex, MaGOmega, and Lipinova brands with customizable potencies (up to 97% EPA), ratios, and delivery formats (EE, TG, DG, MAG).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Omega-3 concentrates up to 97% EPA potency achievable through Flutex technology
+3 more records
Product overview1 text field

Solutex is a leading global manufacturer of omega-3 ingredients and Specialized Pro-Resolving Mediators (SPMs) for the dietary supplements, medical nutrition, pharmaceutical, and cosmetics industries. The company operates as a unified portfolio centered on four core ingredient brands: Omegatex® Marine Sourced (sustainably sourced marine omega-3 concentrates), Omegatex® Plant Based (vegan omega-3 from microalgae), MaGOmega® (enhanced-bioavailability monoglyceride omega-3), and Lipinova® (next-generation SPM ingredients for inflammation resolution). These products are enabled by Solutex's proprietary technology platforms—Flutex® (supercritical CO2 extraction and chromatography), Cleantex® (purification and deodorization), and Emugel™ (nano-emulsion for water solubility)—all backed by the SLTEX Warranty Seal® quality commitment. Ingredients are manufactured in Europe (Spain) for global brands.

Product and service2 records
1Omegatex® Marine Sourced
CategoryOmega-3 Ingredients
Description

Premium marine omega-3 concentrations sustainably sourced from fish oil, offering tailored EPA/DHA ratios up to 97% EPA, 90% DHA, and 35% DPA. Available in EE, TG, DG, and MAG forms with Cleantex® deodorization for reduced fishy aftertaste. Shelf life of 36 months. Targeted at dietary supplement, medical nutrition, pharmaceutical, and cosmetics manufacturers.

2Omegatex® Plant Based
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-04-02
Description

Mutual exclusive distribution agreement for Omegatex brand omega-3 products across EU27 countries. BTC Europe, part of BASF, distributes fish oil and algae oil based Omega-3 products including marine-sourced (with Halal certification) and plant-based (with Kosher & Halal certifications) ingredients. Partnership enables customers to enhance product offerings with sustainably sourced ingredients and expand market reach in Europe.

2La Catedra Solutex / University of Zaragoza
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-02-07
Description

La Catedra Solutex de Quimica Sostenible at University of Zaragoza. Grants two scholarships for Master's degree and internship at Solutex. Organized jointly with Fundacion Ramon Areces for Inflammation Treatment symposium.

solutexcorp.com
3ANIMO3 / Government of Aragon
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-11-19
Description

ANIMO3 project (Research and valorization of non-concentrable side fractions as specialized Omega-3 animal feed) subsidized by Government of Aragon within circular economy projects. Valorization of omega-3 side streams for animal nutrition.

solutexcorp.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-12-11
Description

ARACOV project co-financed 50% by Department of Economy, Planning, and Employment of Government of Aragon (File IDMF/2021/0008). Research trial evaluating improvement in quality of life of Persistent Covid patients through nutritional intervention with SPMs (Lipinova) along with exercise and therapeutic education program.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2020-03-18
Description

MACBETH (Membranes And Catalysts Beyond Economic and Technological Hurdles) project received funding from EU Horizon 2020 research program (grant agreement No 869896). Develops breakthrough technology combining catalytic synthesis with separation units in catalytic membrane reactor for omega-3 enrichment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Dr. Charles Serhan at Harvard Medical School led to discovery of SPMs (Specialized Pro-Resolving Mediators) and development of Lipinova. Dr. Serhan serves as Chairman of Scientific Committee of Solutex. Collaboration on SPM research and inflammation resolution science.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Norwegian fish-oil refiner and omega-3 ingredient supplier producing EPA/DHA concentrates for nutrition and pharma. Direct competitor in marine-sourced omega-3 with overlapping customer base in European supplement brands and similar mid-sized positioning to Solutex.

TypeBroad incumbent
Description

Global nutrition and health ingredient conglomerate with the life'sDHA algal omega-3 brand and broad fish-oil portfolio serving dietary supplements, infant nutrition, and pharma. Competes with Solutex across both marine and plant-based omega-3 categories with much larger scale and customer reach.

TypeBroad incumbent
Description

UK-listed specialty ingredient company with Incromega fish-oil omega-3 concentrates and plant-based equivalents serving nutrition, personal care, and pharma. Comparable product formats, EPA/DHA potency positioning, and application breadth with significantly larger scale.

TypeDirect peer
Description

Norwegian krill oil and marine ingredient specialist with Superba krill oil and QRILL Aqua feed products. Competes with Solutex's marine-sourced Omegatex for premium-positioned omega-3 customers and shares the focus on differentiated, science-backed marine lipid ingredients.

TypeDirect peer
Description

Contract manufacturer of omega-3 EPA/DHA concentrates and custom lipid formulations for pharma and nutraceutical customers. Closest direct peer to Solutex in terms of high-potency omega-3 manufacturing for B2B customers, with overlapping technology platforms.

TypeBroad incumbent
Description

World's largest chemical company with a Human Nutrition division including omega-3 ingredients, and parent of BTC Europe — Solutex's new exclusive EU distributor. Overlaps with Solutex on omega-3 ingredients and is the most strategically important adjacent incumbent given the partnership.

7Polaris (part of Aker BioMarine)
TypeEmerging player
Description

French omega-3 specialty ingredient company acquired by Aker BioMarine, focused on high-concentration EPA/DHA ingredients and phospholipid formats. Comparable mid-sized European positioning to Solutex and a relevant competitor in premium-concentrate omega-3.

TypeEmerging player
Description

US-based microalgae omega-3 (EPA/DHA) producer using Schizochytrium fermentation. Closest emerging competitor to Solutex's Omegatex Plant-Based and MaGOmega lines, focused on the same plant-based, vegan-positioned omega-3 segment.

TypeBroad incumbent
Description

Global agribusiness and ingredient giant with omega-3 ingredients and EPA/DHA-containing oils via its health and nutrition division. Competes with Solutex as a broad incumbent supplying food, supplement, and animal nutrition customers with marine and alternative omega-3 sources.

TypeEmerging player
Description

Dutch ingredient company with algal-based omega-3 (DHA from Crypthecodinium cohnii) sold under the life'sDHA brand historically, now divested but adjacent in fermentation-derived lipid ingredients. Comparable technology positioning and European mid-market scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance17 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Solutex

Omega-3 Nutritional Ingredientssolutexcorp.com

Solutex is a Spain-based B2B manufacturer of highly concentrated omega-3 EPA and DHA ingredients and patented SPM lipid fractions, supplying dietary supplement, medical nutrition, pharmaceutical, and cosmetics formulators worldwide via proprietary supercritical CO2 extraction technology and exclusive distribution partnerships.

What Solutex does

Solutex GC S.L. is a Spain-based, privately held B2B ingredient manufacturer founded in 2004 and headquartered in Alcobendas, Madrid, with a dedicated manufacturing and laboratory campus in Mallén, Zaragoza. The company produces highly concentrated omega-3 EPA and DHA ingredients and Specialized Pro-Resolving Mediators (SPMs), selling to dietary supplement, medical nutrition, pharmaceutical, and cosmetics manufacturers across more than four continents via direct B2B sales and regional distribution.

Its product portfolio is anchored on four ingredient brands — Omegatex Marine Sourced, Omegatex Plant Based (algal, vegan), MaGOmega (microalgae monoglyceride form), and Lipinova (SPM concentrate) — all enabled by a proprietary technology stack centered on Flutex supercritical CO2 fluid extraction and chromatography (enabling up to 97% EPA potency and GRAS status), Cleantex purification and deodorization (patented for heavy metal, PCB, and dioxin removal), and Emugel nano-emulsion for water-soluble delivery. Manufacturing follows a zero-waste, circular-economy model certified under multiple ISO standards, IFOS, Friend of the Sea, GOED, IFFO, Kosher, Halal, and V-Label Vegan.

Solutex monetizes primarily through one-time bulk ingredient sales to brand owners and OEMs, augmented by pharmaceutical licensing (inbound Maresins 1 license from Harvard, developed through subsidiary Maresins BioPharma), specialized Resolution Physiology Laboratory services for SPM bioactivity validation, and an exclusive EU27 distribution agreement with BTC Europe (BASF group) signed April 2, 2025. Pricing is quote-based B2B; the company holds a significant minority stake investment from Nexxus Iberia private equity (January 2022) and operates wholly-owned subsidiaries Azur Global Nutrition (SPM nutrition) and Maresins BioPharma (pharmaceuticals).

Solutex firmographics

Firmographics
Name
Solutex
Legal name
SOLUTEX GC S.L.
Website
https://solutexcorp.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
Solutex is a Spain-based B2B manufacturer of highly concentrated omega-3 EPA and DHA ingredients and patented SPM lipid fractions, supplying dietary supplement, medical nutrition, pharmaceutical, and cosmetics formulators worldwide via proprietary supercritical CO2 extraction technology and exclusive distribution partnerships.
Ownership category
akta.pro rank

Solutex industry classification

Industry
Product category
Omega-3 Nutritional Ingredients
NAICS
Fats and Oils Refining and Blending (311225)
SIC
Fats & Oils (2070), Medicinal Chemicals & Botanical Products (2833), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYAFAJAKAC
Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJALAK
Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates)
Agriculture & Food Production/Food Ingredients & Additives/Fats & Oils Ingredients (Edible Oils, Specialty Fats, Lipid Systems)
SECONDARYAFAJAKAK
Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYCRADAOAO
Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends)

Keywords

  • Omega-3 ingredients
  • Marine omega-3 concentrates
  • Algae omega-3
  • SPM ingredients
  • EPA DHA manufacturing

Where Solutex is headquartered

Location

Headquarters

HQ city
Alcobendas
HQ country
Spain
HQ region
Europe

Offices5 records

Markets served

Solutex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Omega-3 Bulk Ingredients: Sale of bulk omega-3 ingredients including Omegatex Marine Sourced, Omegatex Plant Based, MaGOmega, and Lipinova to dietary supplements, medical nutrition, pharmaceutical and cosmetics manufacturers. Products sold in various forms (EE, TG, DG, MAG) with customized ratios and potencies. Revenue generated through direct B2B sales and distribution partnerships.
  2. Pharmaceutical Licensing: Licensing of SPM patents including Maresins from Harvard University for pharmaceutical ingredient development. Development of pharmaceutical applications from SPM Maresins 1 as potent immunoresolvant through subsidiary Maresins BioPharma.
  3. Resolution Physiology Laboratory Services: Specialized laboratory services to observe SPM activity levels and inflammatory parameters in biological samples. Supports customer product development and validates SPM ingredient efficacy.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Solutex product offering

Product offering

Core offering

Solutex manufactures and sells highly concentrated omega-3 EPA and DHA fatty acid ingredients sourced from fish oil and microalgae, as well as patented Specialized Pro-Resolving Mediators (SPM) ingredients, serving dietary supplements, medical nutrition, pharmaceutical, and cosmetics manufacturers. Products are offered under the Omegatex, MaGOmega, and Lipinova brands with customizable potencies (up to 97% EPA), ratios, and delivery formats (EE, TG, DG, MAG).

Product overview

Solutex is a leading global manufacturer of omega-3 ingredients and Specialized Pro-Resolving Mediators (SPMs) for the dietary supplements, medical nutrition, pharmaceutical, and cosmetics industries. The company operates as a unified portfolio centered on four core ingredient brands: Omegatex® Marine Sourced (sustainably sourced marine omega-3 concentrates), Omegatex® Plant Based (vegan omega-3 from microalgae), MaGOmega® (enhanced-bioavailability monoglyceride omega-3), and Lipinova® (next-generation SPM ingredients for inflammation resolution). These products are enabled by Solutex's proprietary technology platforms—Flutex® (supercritical CO2 extraction and chromatography), Cleantex® (purification and deodorization), and Emugel™ (nano-emulsion for water solubility)—all backed by the SLTEX Warranty Seal® quality commitment. Ingredients are manufactured in Europe (Spain) for global brands.

Differentiator

Problem solved

Functional benefit

Brands

  • Omegatex: Premium omega-3 ingredient brand including Marine Sourced (fish oil) and Plant Based (algae oil) product lines offering EPA and DHA concentrates
  • MaGOmega
  • Lipinova
  • Flutex
  • Cleantex
  • Emugel
  • SLTEX Warranty Seal

Products and services

  • Omegatex® Marine Sourced Premium marine omega-3 concentrations sustainably sourced from fish oil, offering tailored EPA/DHA ratios up to 97% EPA, 90% DHA, and 35% DPA. Available in EE, TG, DG, and MAG forms with Cleantex® deodorization for reduced fishy aftertaste. Shelf life of 36 months. Targeted at dietary supplement, medical nutrition, pharmaceutical, and cosmetics manufacturers.
  • Omegatex® Plant Based

Quantifiable outcome

  • Omega-3 concentrates up to 97% EPA potency achievable through Flutex technology
  • +3 more outcomes

Companies that use Solutex

Customer profile

Segments4 records

Ideal customer profiles4 records

Solutex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Solutex partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, minor and major.

  • BTC EuropecoreChannel Partner/ Reseller/ Distributor · 2 April 2025Mutual exclusive distribution agreement for Omegatex brand omega-3 products across EU27 countries. BTC Europe, part of BASF, distributes fish oil and algae oil based Omega-3 products including marine-sourced (with Halal certification) and plant-based (with Kosher & Halal certifications) ingredients. Partnership enables customers to enhance product offerings with sustainably sourced ingredients and expand market reach in Europe.
  • La Catedra Solutex / University of ZaragozaminorStrategic or Co-development Partner · 7 February 2025La Catedra Solutex de Quimica Sostenible at University of Zaragoza. Grants two scholarships for Master's degree and internship at Solutex. Organized jointly with Fundacion Ramon Areces for Inflammation Treatment symposium.
  • ANIMO3 / Government of AragonminorStrategic or Co-development Partner · 19 November 2024ANIMO3 project (Research and valorization of non-concentrable side fractions as specialized Omega-3 animal feed) subsidized by Government of Aragon within circular economy projects. Valorization of omega-3 side streams for animal nutrition.
  • Government of Aragon / ARACOVminorStrategic or Co-development Partner · 11 December 2023ARACOV project co-financed 50% by Department of Economy, Planning, and Employment of Government of Aragon (File IDMF/2021/0008). Research trial evaluating improvement in quality of life of Persistent Covid patients through nutritional intervention with SPMs (Lipinova) along with exercise and therapeutic education program.
  • MACBETH Consortium (Horizon 2020)majorStrategic or Co-development Partner · 18 March 2020MACBETH (Membranes And Catalysts Beyond Economic and Technological Hurdles) project received funding from EU Horizon 2020 research program (grant agreement No 869896). Develops breakthrough technology combining catalytic synthesis with separation units in catalytic membrane reactor for omega-3 enrichment.
  • Harvard University / Dr. Charles SerhancoreStrategic or Co-development PartnerPartnership with Dr. Charles Serhan at Harvard Medical School led to discovery of SPMs (Specialized Pro-Resolving Mediators) and development of Lipinova. Dr. Serhan serves as Chairman of Scientific Committee of Solutex. Collaboration on SPM research and inflammation resolution science.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Solutex competitors and assessment

Company assessment

Direct peers

  • GC Rieber Oils: Norwegian fish-oil refiner and omega-3 ingredient supplier producing EPA/DHA concentrates for nutrition and pharma. Direct competitor in marine-sourced omega-3 with overlapping customer base in European supplement brands and similar mid-sized positioning to Solutex.
  • Aker BioMarine: Norwegian krill oil and marine ingredient specialist with Superba krill oil and QRILL Aqua feed products. Competes with Solutex's marine-sourced Omegatex for premium-positioned omega-3 customers and shares the focus on differentiated, science-backed marine lipid ingredients.
  • KD Pharma Group: Contract manufacturer of omega-3 EPA/DHA concentrates and custom lipid formulations for pharma and nutraceutical customers. Closest direct peer to Solutex in terms of high-potency omega-3 manufacturing for B2B customers, with overlapping technology platforms.

Broad incumbents

  • dsm-firmenich: Global nutrition and health ingredient conglomerate with the life'sDHA algal omega-3 brand and broad fish-oil portfolio serving dietary supplements, infant nutrition, and pharma. Competes with Solutex across both marine and plant-based omega-3 categories with much larger scale and customer reach.
  • Croda International: UK-listed specialty ingredient company with Incromega fish-oil omega-3 concentrates and plant-based equivalents serving nutrition, personal care, and pharma. Comparable product formats, EPA/DHA potency positioning, and application breadth with significantly larger scale.
  • BASF: World's largest chemical company with a Human Nutrition division including omega-3 ingredients, and parent of BTC Europe — Solutex's new exclusive EU distributor. Overlaps with Solutex on omega-3 ingredients and is the most strategically important adjacent incumbent given the partnership.
  • Cargill: Global agribusiness and ingredient giant with omega-3 ingredients and EPA/DHA-containing oils via its health and nutrition division. Competes with Solutex as a broad incumbent supplying food, supplement, and animal nutrition customers with marine and alternative omega-3 sources.

Emerging players

  • Polaris (part of Aker BioMarine): French omega-3 specialty ingredient company acquired by Aker BioMarine, focused on high-concentration EPA/DHA ingredients and phospholipid formats. Comparable mid-sized European positioning to Solutex and a relevant competitor in premium-concentrate omega-3.
  • AlgiSys: US-based microalgae omega-3 (EPA/DHA) producer using Schizochytrium fermentation. Closest emerging competitor to Solutex's Omegatex Plant-Based and MaGOmega lines, focused on the same plant-based, vegan-positioned omega-3 segment.
  • Corbion: Dutch ingredient company with algal-based omega-3 (DHA from Crypthecodinium cohnii) sold under the life'sDHA brand historically, now divested but adjacent in fermentation-derived lipid ingredients. Comparable technology positioning and European mid-market scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Solutex social profiles

Digital presence

Solutex compliance and trust

Trust signal

Compliance17 records

Solutex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Solutex leadership team

Management profile

Number of profiles

Profiles3 records

Solutex subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Solutex funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Solutex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solutex

What does Solutex do?

Solutex manufactures and sells highly concentrated omega-3 EPA and DHA fatty acid ingredients sourced from fish oil and microalgae, as well as patented Specialized Pro-Resolving Mediators (SPM) ingredients, serving dietary supplements, medical nutrition, pharmaceutical, and cosmetics manufacturers. Products are offered under the Omegatex, MaGOmega, and Lipinova brands with customizable potencies (up to 97% EPA), ratios, and delivery formats (EE, TG, DG, MAG).

Is Solutex a public or private company?

Solutex is a private company. It is classified as family owned and is currently operating.

When was Solutex founded?

Solutex was founded in 2004. It employs 51 to 100 people.

Where is Solutex based?

Solutex is headquartered in Alcobendas, Spain, in the Europe region.

How does Solutex make money?

Three revenue lines are on record. Omega-3 Bulk Ingredients are the primary driver. The others are pharmaceutical Licensing and resolution Physiology Laboratory Services.

Who are Solutex's main competitors?

Direct peers on record are GC Rieber Oils, Aker BioMarine and KD Pharma Group. Broad incumbents are dsm-firmenich, Croda International, BASF and Cargill. Emerging players are Polaris (part of Aker BioMarine), AlgiSys and Corbion.

Does Solutex have an API?

No public API is recorded for Solutex.

What industry is Solutex in?

Solutex's product category is Omega-3 Nutritional Ingredients. Its primary akta.pro industry code is AFAJAKAC, Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids), with a secondary code of AFAJALAK, Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates). Its NAICS code is 311225 and its SIC code is 2070.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales